PPARγ agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells
- 1 June 2010
- journal article
- Published by Elsevier BV in Pharmacological Research
- Vol. 61 (6), 489-498
- https://doi.org/10.1016/j.phrs.2010.03.002
Abstract
No abstract availableKeywords
Funding Information
- National Project “Knowledge Cluster Initiative”
- Ministry of Education, Culture, Sports Science, and Technology
- Ministry of Health, Labour and Welfare of Japan
This publication has 42 references indexed in Scilit:
- Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitroMedical Molecular Morphology, 2009
- Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cellsCell and tissue research, 2009
- PPARα and PPARγ attenuate HIV‐induced dysrégulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activitiesThe FASEB Journal, 2009
- Epithelium: At the interface of innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2007
- Modulation of PPAR activity via phosphorylationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental ColitisJournal of Clinical Immunology, 2007
- Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor γMolecular and Cellular Biology, 2007
- PPARγ‐regulated tight junction development during human urothelial cytodifferentiationJournal of Cellular Physiology, 2006
- Tight junctions and human diseasesMedical Molecular Morphology, 2003
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996